Cargando…
Retraction
Gao Y, Wang F, Zhang L, et al. LINC00311 promotes cancer stem‐like properties by targeting miR‐330‐5p/TLR4 pathway in human papillary thyroid cancer. Cancer Med. 2020; 9: 1515–1528. https://doi.org/10.1002/cam4.2815. The above article, published online on 02 January 2020 in Wiley Online Library (wil...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225171/ https://www.ncbi.nlm.nih.gov/pubmed/37050853 http://dx.doi.org/10.1002/cam4.5823 |
| _version_ | 1785050341871452160 |
|---|---|
| collection | PubMed |
| description | Gao Y, Wang F, Zhang L, et al. LINC00311 promotes cancer stem‐like properties by targeting miR‐330‐5p/TLR4 pathway in human papillary thyroid cancer. Cancer Med. 2020; 9: 1515–1528. https://doi.org/10.1002/cam4.2815. The above article, published online on 02 January 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by the journal's Editor‐in‐Chief, Dr Stephen Tait, and John Wiley & Sons Ltd. The retraction has been agreed due to concerns regarding image manipulation, which were brought to the journal's attention by a third party. A detailed investigation confirmed substantial inconsistencies. As a result, the journal no longer has confidence in the results and conclusions reported. |
| format | Online Article Text |
| id | pubmed-10225171 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102251712023-05-29 Retraction Cancer Med Retraction Gao Y, Wang F, Zhang L, et al. LINC00311 promotes cancer stem‐like properties by targeting miR‐330‐5p/TLR4 pathway in human papillary thyroid cancer. Cancer Med. 2020; 9: 1515–1528. https://doi.org/10.1002/cam4.2815. The above article, published online on 02 January 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by the journal's Editor‐in‐Chief, Dr Stephen Tait, and John Wiley & Sons Ltd. The retraction has been agreed due to concerns regarding image manipulation, which were brought to the journal's attention by a third party. A detailed investigation confirmed substantial inconsistencies. As a result, the journal no longer has confidence in the results and conclusions reported. John Wiley and Sons Inc. 2023-04-12 /pmc/articles/PMC10225171/ /pubmed/37050853 http://dx.doi.org/10.1002/cam4.5823 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Retraction |
| title | Retraction |
| title_full | Retraction |
| title_fullStr | Retraction |
| title_full_unstemmed | Retraction |
| title_short | Retraction |
| title_sort | retraction |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225171/ https://www.ncbi.nlm.nih.gov/pubmed/37050853 http://dx.doi.org/10.1002/cam4.5823 |